Rock Edwin insider trades
Rock Edwin has filed 7 Form 4s with the SEC that we hold, all for Crescent Biopharma, INC. (GLYC), as Chief Medical Officer. Across all of them we count 7 purchases worth $725.3K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 110,000 shares of Crescent Biopharma, INC. worth $247.5K, dated 2022-12-22. The first filing on our record is dated 2022-09-07 and the latest 2024-06-24.
Crescent Biopharma, INC. (GLYC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-14 | P, purchase reported on Form 4 | 100,000 | $143.0K | 2022-11-16 |
| 2022-11-15 | P, purchase reported on Form 4 | 100,000 | $166.0K | 2022-11-16 |
| 2022-12-22 | P, purchase reported on Form 4 | 110,000 | $247.5K | 2022-12-27 |
| 2023-09-21 | P, purchase reported on Form 4 | 35,000 | $48.3K | 2023-09-25 |
| 2023-09-22 | P, purchase reported on Form 4 | 30,403 | $42.0K | 2023-09-25 |
| 2024-06-20 | P, purchase reported on Form 4 | 190,000 | $47.5K | 2024-06-24 |
| 2024-06-21 | P, purchase reported on Form 4 | 115,000 | $31.1K | 2024-06-24 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1945417) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms